• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HAb18G/CD147 通过调节膜联蛋白 II 激活的 RhoA 和 Rac1 信号通路促进肝癌细胞的迁移。

HAb18G/CD147 promotes cell motility by regulating annexin II-activated RhoA and Rac1 signaling pathways in hepatocellular carcinoma cells.

机构信息

Cell Engineering Research Center and Department of Cell Biology, State Key Laboratory of Cancer Biology, National Key Discipline of Cell Biology, Fourth Military Medical University, Xi'an, PR China.

出版信息

Hepatology. 2011 Dec;54(6):2012-24. doi: 10.1002/hep.24592.

DOI:10.1002/hep.24592
PMID:21809360
Abstract

UNLABELLED

Tumor cells can move as individual cells in two interconvertible modes: mesenchymal mode and amoeboid mode. Cytoskeleton rearrangement plays an important role in the interconversion. Previously, we reported that HAb18G/CD147 and annexin II are interacting proteins involved in cytoskeleton rearrangement, yet the role of their interaction is unclear. In this study we found that the depletion of HAb18G/CD147 produced a rounded morphology, which is associated with amoeboid movement, whereas the depletion of annexin II resulted in an elongated morphology, which is associated with mesenchymal movement. The extracellular portion of HAb18G/CD147 can interact with a phosphorylation-inactive mutant of annexin II and inhibit its phosphorylation. HAb18G/CD147 inhibits Rho signaling pathways and amoeboid movement by inhibiting annexin II phosphorylation, promotes membrane localization of WAVE2 and Rac1 activation by way of the integrin-FAK-PI3K/PIP3 signaling pathway, and promotes the formation of lamellipodia and mesenchymal movement.

CONCLUSION

These results suggest that the interaction of HAb18G/CD147 with annexin II is involved in the interconversion between mesenchymal and amoeboid movement of hepatocellular carcinoma cells.

摘要

未加标签

肿瘤细胞可以以两种可转换的模式作为单个细胞移动:间质模式和阿米巴样模式。细胞骨架重排在相互转换中起着重要作用。以前,我们报道了 HAb18G/CD147 和膜联蛋白 II 是参与细胞骨架重排的相互作用蛋白,但它们相互作用的作用尚不清楚。在这项研究中,我们发现 HAb18G/CD147 的耗竭产生了圆形形态,与阿米巴样运动相关,而膜联蛋白 II 的耗竭导致了伸长形态,与间质运动相关。HAb18G/CD147 的细胞外部分可以与膜联蛋白 II 的磷酸化非活性突变体相互作用并抑制其磷酸化。HAb18G/CD147 通过抑制膜联蛋白 II 的磷酸化抑制 Rho 信号通路和阿米巴样运动,通过整合素-FAK-PI3K/PIP3 信号通路促进 WAVE2 的膜定位和 Rac1 的激活,并促进片状伪足和间质运动的形成。

结论

这些结果表明,HAb18G/CD147 与膜联蛋白 II 的相互作用参与了肝癌细胞间质和阿米巴样运动之间的转换。

相似文献

1
HAb18G/CD147 promotes cell motility by regulating annexin II-activated RhoA and Rac1 signaling pathways in hepatocellular carcinoma cells.HAb18G/CD147 通过调节膜联蛋白 II 激活的 RhoA 和 Rac1 信号通路促进肝癌细胞的迁移。
Hepatology. 2011 Dec;54(6):2012-24. doi: 10.1002/hep.24592.
2
CD147 promotes Src-dependent activation of Rac1 signaling through STAT3/DOCK8 during the motility of hepatocellular carcinoma cells.在肝癌细胞迁移过程中,CD147通过STAT3/DOCK8促进Rac1信号通路的Src依赖性激活。
Oncotarget. 2015 Jan 1;6(1):243-57. doi: 10.18632/oncotarget.2801.
3
Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147.膜联蛋白 II 通过与其相互作用促进人肝癌细胞的体外侵袭和迁移。
Cancer Sci. 2010 Feb;101(2):387-95. doi: 10.1111/j.1349-7006.2009.01420.x. Epub 2009 Nov 2.
4
CD147 regulates cancer migration via direct interaction with Annexin A2 and DOCK3-β-catenin-WAVE2 signaling.CD147通过与膜联蛋白A2直接相互作用以及DOCK3-β-连环蛋白-WAVE2信号传导来调节癌症迁移。
Oncotarget. 2016 Feb 2;7(5):5613-29. doi: 10.18632/oncotarget.6723.
5
Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates.Rac和Rho信号传导在三维基质中癌细胞迁移中的作用。
Oncogene. 2009 Apr 2;28(13):1570-83. doi: 10.1038/onc.2009.2. Epub 2009 Feb 23.
6
HAb18G/CD147 is involved in TGF-β-induced epithelial-mesenchymal transition and hepatocellular carcinoma invasion.HAb18G/CD147参与转化生长因子-β诱导的上皮-间质转化及肝癌侵袭。
Cell Biol Int. 2015 Jan;39(1):44-51. doi: 10.1002/cbin.10341. Epub 2014 Aug 11.
7
HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma.HAb18G/CD147在肝细胞癌的侵袭和转移中发挥作用。
Mol Cancer Res. 2007 Jun;5(6):605-14. doi: 10.1158/1541-7786.MCR-06-0286.
8
siRNA targeted against HAb18G/CD147 inhibits MMP-2 secretion, actin and FAK expression in hepatocellular carcinoma cell line via ERK1/2 pathway.靶向HAb18G/CD147的小干扰RNA通过ERK1/2信号通路抑制肝癌细胞株中MMP-2的分泌、肌动蛋白和黏着斑激酶的表达。
Cancer Lett. 2007 Mar 18;247(2):336-44. doi: 10.1016/j.canlet.2006.05.017. Epub 2006 Jul 3.
9
BetaIg-h3 is involved in the HAb18G/CD147-mediated metastasis process in human hepatoma cells.βIg-h3参与人肝癌细胞中HAb18G/CD147介导的转移过程。
Exp Biol Med (Maywood). 2007 Mar;232(3):344-52.
10
Effects of HAb18G/CD147 knockout on hepatocellular carcinoma cells in vitro using a novel zinc-finger nuclease-targeted gene knockout approach.使用新型锌指核酸酶靶向基因敲除方法在体外研究HAb18G/CD147基因敲除对肝癌细胞的影响。
Cell Biochem Biophys. 2015 Mar;71(2):881-90. doi: 10.1007/s12013-014-0278-9.

引用本文的文献

1
Research and development prospects of TRIM65.TRIM65的研发前景
J Cancer Res Clin Oncol. 2025 Aug 22;151(8):232. doi: 10.1007/s00432-025-06285-9.
2
SARS-CoV-2 Spike Protein and Long COVID-Part 2: Understanding the Impact of Spike Protein and Cellular Receptor Interactions on the Pathophysiology of Long COVID Syndrome.严重急性呼吸综合征冠状病毒2刺突蛋白与新冠后综合征——第2部分:了解刺突蛋白与细胞受体相互作用对新冠后综合征病理生理学的影响
Viruses. 2025 Apr 25;17(5):619. doi: 10.3390/v17050619.
3
Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma.
用于肝细胞癌诊断和治疗选择的生物标志物。
Mol Cancer. 2024 Sep 6;23(1):189. doi: 10.1186/s12943-024-02101-z.
4
Alarmin S100A8 imparts chemoresistance of esophageal cancer by reprogramming cancer-associated fibroblasts.警报素 S100A8 通过重编程癌相关成纤维细胞赋予食管癌的化学抗性。
Cell Rep Med. 2024 Jun 18;5(6):101576. doi: 10.1016/j.xcrm.2024.101576. Epub 2024 May 21.
5
Hypoxia-activated ADCC-enhanced humanized anti-CD147 antibody for liver cancer imaging and targeted therapy with improved selectivity.用于肝癌成像和靶向治疗的缺氧激活的ADCC增强型人源化抗CD147抗体,具有更高的选择性。
MedComm (2020). 2024 Mar 11;5(3):e512. doi: 10.1002/mco2.512. eCollection 2024 Mar.
6
Migrasomes and tetraspanins in hepatocellular carcinoma: current status and future prospects.肝细胞癌中的迁移小体和四跨膜蛋白:现状与未来展望
Future Sci OA. 2023 Aug 8;9(9):FSO890. doi: 10.2144/fsoa-2023-0086. eCollection 2023 Oct.
7
Genetic Variants within SARS-CoV-2 Human Receptor Genes May Contribute to Variable Disease Outcomes in Different Ethnicities.SARS-CoV-2 人类受体基因内的遗传变异可能导致不同种族的疾病结局存在差异。
Int J Mol Sci. 2023 May 13;24(10):8711. doi: 10.3390/ijms24108711.
8
Chemotherapy-induced metastasis: molecular mechanisms and clinical therapies.化疗诱导的转移:分子机制与临床治疗。
Acta Pharmacol Sin. 2023 Sep;44(9):1725-1736. doi: 10.1038/s41401-023-01093-8. Epub 2023 May 11.
9
SH3BP1 Regulates Melanoma Progression Through Race1/Wace2 Signaling Pathway.SH3BP1通过Race1/Wace2信号通路调控黑色素瘤进展。
Clin Med Insights Oncol. 2023 Apr 21;17:11795549231168075. doi: 10.1177/11795549231168075. eCollection 2023.
10
Role of CD147 in the development and diagnosis of hepatocellular carcinoma.CD147 在肝细胞癌发生发展及诊断中的作用。
Front Immunol. 2023 Apr 6;14:1149931. doi: 10.3389/fimmu.2023.1149931. eCollection 2023.